Hematological Malignancy
1 competing product in clinical development for Hematological Malignancy.
Pipeline by Phase
Phase 11
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| isavuconazonium sulfate - intravenous + isavuconazonium sulfate - oral | Astellas Pharma | Phase 1 | Completed | 29 |